betkolik betlike betpark betticket betturkey extrabet holiganbet ilbet ikimisli imajbet jojobet kralbet mariobet marsbahis meritking milanobet piabet redwin süpertotobet tempobet
Abdeen Mustafa Omer Author
Subjects of specialization
Affiliation
Arthritic conditions, Bursa inflammation (Bursitis), Fibrositis (Fibromyalgia syndrome), Fractures, Kyphosis
Chairman & Managing Director of StemRx Bioscience Solutions Pvt. Ltd., Navi Mumbai, India
Pradeep V Mahajan is a Urosurgeon by qualification with additional training in Regenerative medicine and cell-based therapy. He established his brainchild StemRx Bioscience Solutions Pvt. Ltd. in the year 2011. Through this, he continues to set high standards in cell-based therapy for treatment of various degenerative disorders where the limits of conventional therapy end. StemRx has a state of the art GMP compliant and FDA approved facility and aims to provide affordable healthcare that will enable patients to enjoy an improved quality of life
Short Communication Open Access
Author(s): Abdeen Mustafa Omer
The strategy of price liberalisation and privatisation had been implemented in Sudan over the last decade, and has had a positive result on government deficit. The investment law approved recently has good statements and rules on the above strategy in particular to pharmacy regulations. Under the pressure of the new privatisation policy, the government introduced radical changes in the pharmacy regulations. The 2001 Pharmacy and Poisons Act and its provisions established the Federal Pharmacy and Poison Board (FPPB). All the authorities of the implementation of Pharmacy and Poisons Act were given to this board. This article provides an overview of the impact of the pharmaceutical regulations on the quality of medicines on the Sudanese market from the perspective of the pharmacists working w... view more»